Eversept Partners’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Eversept Partners's SMMT Position: Q3 2026 in Review
Eversept Partners opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 526,646 shares worth $8.91M. The stake represents 0.48% of the portfolio and ranks #44 among its holdings.
298 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Eversept Partners held 526,646 shares of Summit Therapeutics worth $8.91M as of Q3 2026.
- Summit Therapeutics was a new Eversept Partners position in Q3 2026.
- Summit Therapeutics made up 0.48% of Eversept Partners's portfolio in Q3 2026, its #44 holding.
- 298 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Eversept Partners's 13F filing for Q3 2026, filed 16 Nov 2026.